{"transactions":[{"id":1695458,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":95624,"kind":"person","name":"Clarke Dorothy J","position":1,"cik":"0001992152","reported_name":"Clarke Dorothy J","relationship":{"director":true,"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:01:31.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":168521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, 25% of the shares underlying the stock option will vest on the nine-month anniversary of the grant date, and the remaining shares underlying the stock option will vest in 39 substantially equal monthly installments thereafter."}],"balance_after":168521,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.005 per share","underlying_shares":168521},"source":{"system":"sec-edgar","filing":"0001140361-24-000468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036124000468/form4.xml","form_type":"4"}},{"id":1744304,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":95624,"kind":"person","name":"Clarke Dorothy J","position":1,"cik":"0001992152","reported_name":"Clarke Dorothy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase","published_at":"2023-11-13T06:31:17.000Z","date":"2023-11-07","kind":"grant","planned":false,"acquired":true,"shares":14200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The stock option shall vest over three (3) years, with one-third of the shares of common stock underlying the option vesting on November 7, 2024, and the remainder vesting in equal monthly installments thereafter."}],"balance_after":14200,"derivative":{"exercise_price":0.355,"expiration_date":"2033-11-07","underlying":"Common Stock","underlying_shares":14200},"source":{"system":"sec-edgar","filing":"0001062993-23-020478","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1992152/000106299323020478/form4.xml","form_type":"4"}}]}